Paul is new CEO at EvaluatePharma

Share this article:

EvaluatePharma named Debbie Paul to the position of CEO Americas, EvaluatePharma USA, effective immediately.

In the new post, Paul is leading the data analysis and forecasting firm's North American operations and its strategic expansion into Canada and Latin America. Jonathan de Pass remains as chief executive of the UK-based parent company, EvaluatePhar­ma Ltd., which he founded.

Paul has been with the firm since 2004, most recently serving as SVP, North America, and has 25 years of healthcare and life science industry experience, ranging from being a critical-care nurse manager to directing market research for Sandoz.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions